All Articles

At a major San Francisco summit, Chinese biotechs unveiled breakthrough heart and cancer drugs, signaling a strategic shift from manufacturing to global innovation.

North European Oil Royalty Trust sees a leadership change as its veteran director exits. A seasoned insider takes the helm, ensuring continuity for investors.

Facing severe cash burn, cognitive computing firm VERSES AI lays off half its workforce in a drastic bid to focus on its Genius platform and achieve profitability.

With a fresh $2.5 million in capital, AlphaGen Intelligence Corp. is poised to expand its 3D content and AI platforms in a competitive tech landscape.

Lexington's first medical cannabis dispensary, Speakeasy, serves 500 patients on day one, signaling strong demand in Kentucky's new, evolving market.

After a major stock sell-off and weak guidance, all eyes are on Energizer's Q1 results and leadership's strategy to navigate a challenging market.

Phosphate producer Itafos appoints Joseph McConnell, a key executive from its main investor, to its board, hinting at a new era of strategic oversight.

CryptoStar extends its crucial $2.25M funding round again, relying heavily on insider investment to fuel a risky but necessary pivot from crypto to AI.

Toro Corp. paid a massive special dividend, exciting investors. We dig into the cash-vs-stock option, market reaction, and what it means for the firm's future.

Killam Apartment REIT's steady distribution highlights its reliability, but how does its $5.6B portfolio stack up in Canada's evolving housing landscape?

With sales falling and analysts wary, Hain Celestial's upcoming earnings report will be a key indicator of its turnaround progress in a competitive market.

Denver-based York Space Systems is going public, aiming to raise over half a billion dollars. Can its agile model disrupt the legacy defense industry?

Hong Kong-based Cellyan Biotechnology has 180 days to rescue its Nasdaq listing after its stock price fell below the $1.00 minimum requirement.

After two rejections, Metallus and USW Local 1123 have a new four-year deal. Will the third time be the charm for 1,200 Canton workers?

A historic $5M donation from an alumna and her husband will fund scholarships at Neumann University, tackling the nursing shortage and boosting social mobility.

Innovation Beverage Group is on the clock with Nasdaq after failing to hold its annual meeting, raising questions about its governance and listing future.

With final regulatory approval secured, the $1.44B AAM-Dowlais combination is set to create a $12B global leader in automotive components.

With its stock near a 52-week low, Conduent brings in a six-time CEO to lead a turnaround and boost profitability. Can the new leadership team deliver?

Following key acquisitions, Ntracts promotes six executives, signaling a major push to unify its platform and tackle healthcare's growing complexity.

As Silgan prepares its 2025 results, investors eye if its sustainable packaging strategy can navigate revised guidance and fierce competition.